Table 4.
Gender-specific presence and OR of high CHD risk depending on the number of MS components.
| n | CHD, n (%) | OR (95% CI) | Stroke, n (%) | OR (95% CI) | |
|---|---|---|---|---|---|
| Men | |||||
| 1 | 62 | 16 (25.8%) | 1.0 | 2 (3.2%) | 1.0 |
| 2 | 231 | 121 (52.4%) | 3.16 (1.69, 5.91)‡ | 33 (14.3%) | 5.0 (1.2, 21.4)∗ |
| 3 | 235 | 126 (53.6%) | 3.32 (1.78, 6.20)‡ | 43 (18.2%) | 6.7 (1.6, 28.6)∗ |
| 4 | 182 | 114 (62.6%) | 4.82 (2.53, 9.17)‡ | 27 (14.8%) | 5.2 (1.2, 22.7)∗ |
| 5 | 86 | 51 (59.3%) | 4.19 (2.05, 8.55)‡ | 10 (19.6%) | 3.9 (0.833, 18.7) |
| Women | |||||
| 1 | 23 | 1 (4.3%) | 1.0 | 1 (4.3%) | 1.0 |
| 2 | 102 | 17 (16.7%) | 4.40 (0.56, 34.9) | 4 (3.9%) | 0.9 (0.1, 8.4) |
| 3 | 191 | 41 (21.5%) | 6.01 (0.79, 45.9) | 18 (9.4%) | 2.3 (0.3, 18.0) |
| 4 | 236 | 74 (31.4%) | 10.0 (1.33, 76.0)∗ | 27 (11.3%) | 2.8 (0.4, 21.9) |
| 5 | 166 | 58 (34.9%) | 11.8 (1.55, 89.9)∗ | 12 (7.2%) | 1.7 (0.2, 13.8) |
∗ p < 0.05 and ‡ p < 0.001 compared to subjects with type 2 diabetes mellitus without other components of MS. The 10-year CHD and stroke risk were estimated using the UKPDS risk engine with individuals categorized as high risk (>20% risk). CHD: coronary heart disease; MS: metabolic syndrome; OR: odds ratio.